Rational combination therapy in refractory migraine.
Refractory migraine (RM) headaches pose important treatment challenges to the patients who live with them and the clinicians who try to treat them. Defined based on the lack of response to acute, preventive, and nonpharmacologic treatment, RM is often treated with a combination of treatments. Although combination therapy for RM has not been systematically studied in randomized trials, clinical experience suggests that a rational approach to RM treatment, utilizing a combination of treatments, may be effective where monotherapy has failed. In this article we briefly identify patient populations appropriate for more aggressive migraine prevention with combination therapy. We then discuss modifiable risk factors and comorbidities in migraine and then focus on the use of rational combination therapy, as well as the duration migraine preventatives should be considered for use. Future research is needed to evaluate the full potential of rational combination treatment as a strategy for treating and ultimately preventing RM.
Peterlin
B Lee
BL
Department of Neurology, Drexel University College of Medicine, Philadelphia, PA, USA.
Calhoun
Anne H
AH
Siegel
Sherry
S
Mathew
Ninan T
NT
D001905:Botulinum Toxins / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D004185:Disability Evaluation; D004359:Drug Therapy, Combination; D020773:Headache Disorders / Q000628:therapy*; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*; D009407:Nerve Block; D010148:Intractable Pain / Q000628:therapy*; D016896:Treatment Outcome
D001905:Botulinum Toxins